Societal CDMO(REPH)
2.09 0.00 0.0%
| 今开：0.0 | 昨收：2.09 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.17926555E8 |
Societal CDMO的最新讨论
牛唐2019-03-18 17:34
$Recro制药(REPH)$ 的N1539治疗术后疼痛在去年吃了CRL，主要原因是数据及次要终点的选择不符合FDA的预期，这个月24号第二次申请，过的概率有，但不会很大查看全文
![[加]](http://js.xueqiu.com/ugc/images/face/emoji_52_plus.png?v=1 "[加]"){kind=small}
![[哭泣]](http://js.xueqiu.com/ugc/images/face/emoji_09_cry.png?v=1 "[哭泣]"){kind=small}
Societal CDMO的公告
$Recro Pharma(REPH)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2016-02-01 AccNo: 0001193125-16-445429 Size: 56 KB 网页链接
$Recro Pharma(REPH)$ 8-K - Current report Filed: 2016-01-27 AccNo: 0001193125-16-439874 Size: 45 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Recro Pharma(REPH)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2016-01-27 AccNo: 0001193125-16-440014 Size: 56 KB 网页链接
$Recro Pharma(REPH)$ EFFECT - Notice of Effectiveness Filed: 2016-01-11 AccNo: 9999999995-16-003498 Size: 1 KB 网页链接
$Recro Pharma(REPH)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-01-11 AccNo: 0001535610-16-000094 Size: 14 KB 网页链接
$Recro Pharma(REPH)$ 8-K - Current report Filed: 2016-01-11 AccNo: 0001193125-16-426113 Size: 14 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Recro Pharma(REPH)$ 8-K - Current report Filed: 2016-01-06 AccNo: 0001193125-16-421986 Size: 34 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Recro Pharma(REPH)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2015-12-23 AccNo: 0001193125-15-412962 Size: 108 KB 网页链接
$Recro Pharma(REPH)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2015-12-23 AccNo: 0001193125-15-412960 Size: 68 KB 网页链接
$Recro Pharma(REPH)$ POS AM - Post-Effective amendments for registration statement Filed: 2015-12-23 AccNo: 0001193125-15-412974 Size: 1 MB 网页链接